Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Scientific Reports|July 23, 2020
The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cellsDong Kyu Choi, Young Kyu Kim, Sang Wook Park, et al.Cancer Research and Treatment|September 27, 2023
A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia PatientsJa Min Byun, Junghoon Shin, Sang-A Kim, et al.Cancer Medicine|April 13, 2026
Comparative Outcomes of Consolidation Strategies After R-MVP Induction in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemSang-A Kim, Jung Sun Kim, Ji Yun Lee, et al.Haematologica|June 18, 2026
Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphomaJi Yun Lee, Sang-A Kim, Deok-Hwan Yang, et al.Annals of Laboratory Medicine|June 29, 2022
Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1Sang Mee Hwang, Beom Joon Kim, Jee-Soo Lee, et al.Current Problems in Cancer|September 5, 2021
Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in KoreaJa Min Byun, Sang-A Kim, Youngil Koh, et al.Journal of Cancer Research and Clinical Oncology|May 3, 2020
Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastasesSang-A Kim, Ji-Won Kim, Koung Jin Suh, et al.Thrombosis Research|March 25, 2022
Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based studyJi Yun Lee, Ju-Hyun Lee, Sang-A Kim, et al.Thoracic Cancer|November 9, 2022
The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitorsJieun Yang, Se Hyun Kim, Eun Hee Jung, et al.British Journal of Haematology|October 10, 2024
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndromeDong Hyun Kim, Seokhyeon Kim, Seonyang Park, et al.Pageof 7